Position in NBIX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$10,150,152
+$4,406,684 QoQ
Shares Held
60,224
+38.1% QoQ
Ownership
0.059%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#155
of 768 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NATIXIS ADVISORS, LLC holds $144,607,995 across 17 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (7.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
6,652,349 | $62,066,416 | |
| 2 | TEVA |
Teva Pharmaceutical Industries Ltd
|
567,585 | $19,229,779 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
60,224 | $10,150,152 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
17,340 | $9,395,332 | |
| 5 | PBH |
Prestige Consumer Healthcare Inc.
|
184,209 | $8,707,559 | |
| 6 | VTRS |
Viatris Inc
|
472,511 | $7,503,474 | |
| 7 | ZTS |
Zoetis Inc.
|
96,209 | $6,913,578 | |
| 8 | TAK |
Takeda Pharmaceutical Co Ltd
|
268,328 | $4,301,297 |
All Filings in NBIX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,150,152 | 60,224 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $5,743,468 | 43,597 | Shares | Defined | 2026-05-13 | |
| 2025-12-31 | $5,851,338 | 41,256 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $6,006,298 | 42,786 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,574,110 | 36,392 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $3,684,307 | 33,312 | Shares | Defined | 2025-05-08 | |
| 2024-12-31 | $4,586,946 | 33,604 | Shares | Defined | 2025-02-10 | |
| 2024-09-30 | $3,379,056 | 29,327 | Shares | Defined | 2024-11-06 | |
| 2024-06-30 | $4,854,244 | 35,260 | Shares | Defined | 2024-08-01 | |
| 2024-03-31 | $4,376,063 | 31,729 | Shares | Defined | 2024-04-25 | |
| 2023-12-31 | $3,930,532 | 29,831 | Shares | Defined | 2024-02-06 | |
| 2023-09-30 | $3,413,587 | 30,343 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $2,335,811 | 24,770 | Shares | Defined | 2023-08-15 | |
| 2023-03-31 | $5,491,286 | 54,251 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $7,308,772 | 61,192 | Shares | Defined | 2023-01-27 | |
| 2022-09-30 | $7,483,769 | 70,462 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $6,511,176 | 66,795 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $5,657,718 | 60,349 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $2,350,947 | 27,603 | Shares | Defined | 2022-02-08 | |
| 2021-09-30 | $3,934,420 | 41,022 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $3,419,046 | 35,132 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $3,310,195 | 34,038 | Shares | Defined | 2021-05-05 | |
| 2020-12-31 | $2,912,306 | 30,384 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $3,270,978 | 34,016 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $1,831,586 | 15,013 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $1,260,773 | 14,567 | Shares | Defined | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||